Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Pacira Pharmaceuticals sell JPMorgan Chase & Co.

Pacira Pharmaceuticals
Start price
€11.10
12.08.24 / 50%
Target price
€9.16
12.08.25
Performance (%)
2.70%
Price
€11.00
13.08.24
Summary
This prediction is currently active. With a performance of 2.70%, the SELL prediction by JPMorgan_Chase___Co_ for Pacira Pharmaceuticals is trending in the wrong direction This prediction currently runs until 12.08.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w
Pacira Pharmaceuticals 2.70%
iShares Core DAX® 2.722%
iShares Nasdaq 100 4.546%
iShares Nikkei 225® 6.353%
iShares S&P 500 3.194%

Comments by JPMorgan_Chase___Co_ for this prediction

In the thread Pacira Pharmaceuticals diskutieren
Prediction Sell
Perf. (%) 2.70%
Target price 9.155
Change
Ends at 12.08.25

Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "underweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $10.00 price target on the stock, down previously from $45.00.
Ratings data for PCRX provided by MarketBeat

JPMorgan Chase & Co. 
0
Report Share
12.08.24

Stopped prediction by JPMorgan_Chase___Co_ for Pacira Pharmaceuticals

buy
Pacira Pharmaceuticals

Start price
Target price
Perf. (%)
€28.20
07.03.24
€41.38
07.03.25
-61.70%
13.08.24

JPMorgan Chase & Co. 
07.03.24 50%